Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer
2011

Angiopoietin-2 and CRP in Colorectal Cancer

Sample size: 344 publication 10 minutes Evidence: high

Author Information

Author(s): Volkova E, Willis J A, Wells J E, Robinson B A, Dachs G U, Currie M J

Primary Institution: University of Otago Christchurch

Hypothesis

Obesity-related chronic hyperinsulinemia and insulin resistance promote a pro-inflammatory and pro-angiogenic environment that stimulates tumour growth and metastasis, leading to poor survival.

Conclusion

The study confirms serum Ang-2 as a predictive marker for the outcome of colorectal cancer.

Supporting Evidence

  • Serum Ang-2 and VEGF-A levels increased with tumor T stage.
  • Patients with high serum levels of CRP and Ang-2 had significantly reduced survival.
  • Ang-2 remained a significant predictor of survival after adjusting for tumor stage and age.

Takeaway

This study found that inflammation from obesity is linked to worse outcomes in colorectal cancer, and high levels of a protein called Ang-2 can help predict survival.

Methodology

Clinical and pathological data were collected from 344 colorectal cancer patients, and serum samples were analyzed for various markers.

Limitations

The study did not determine waist circumference, and the small number of patients with type 2 diabetes may limit the findings.

Participant Demographics

The cohort included 173 males and 171 females, with ages ranging from 31 to 91 years, and 20% were AJCC stage I, 42% stage II, 34% stage III, and 4% stage IV.

Statistical Information

P-Value

P=0.007 for Ang-2 and P=0.025 for VEGF-A with tumor T stage.

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6606005

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication